Skip to main content
. 2008 Oct 23;8:102. doi: 10.1186/1471-213X-8-102

Table 2.

Samples included in this study

Bar Code No. Name Description Fetus age Source
1521406071H 1 SM060310 Unsorted fetal brain cells 20 weeks Q therapeutics
1521406071F 2 NAE050421 A2B5+, PSA-NCAM- cells 20 weeks Q therapeutics
1521406071G 3 NAE060615 A2B5+, PSA-NCAM- cells 23 weeks Q therapeutics
1521406071C 4 AE060609–93 A2B5+ cells 21 weeks Q therapeutics
1521406071D 5 AE060617 A2B5+ cells 21 weeks Q therapeutics
1521406071E 6 AE060309 A2B5+ cells 20 weeks Q therapeutics
1521406071A 7 NE060309 PSA-NCAM+ cells 20 weeks Q therapeutics
1521406071B 8 NE060310 PSA-NCAM+ cells 20 weeks Q therapeutics
1334328027F 9 HOPC A2B5+, PSA-NCAM- cells NA Steve Goldman
1334328026C 10 HOPC replicate A2B5+, PSA-NCAM- cells NA Steve Goldman
1400364009C 11 WB-015 Neurosphere from whole brain NA Cognate
1400364009D 12 FB-017 Neurosphere from frontal brain NA Cognate
1400401019A 13 hAPC CD44+ cells 20–22 weeks Mahendra Rao
1334328022D 14 hAPC replicate CD44+ cells 20–22 weeks Mahendra Rao
1334328023C 15 hAPC replicate CD44+ cells 20–22 weeks Mahendra Rao
1400401019B 16 hAST line Human astrocyte line NA Ahmet Hoke
1400401019C 17 hSC line Human Schwann line NA Ahmet Hoke